Advertisement

Topics

Companies Related to "Post-Authorization Safety Study of GSK Biologicals' Pandemic Influenza Vaccine (H1N1) in the United Kingdom" [Most Relevant Company Matches] - Page: 2 RSS

09:51 EST 21st November 2018 | BioPortfolio

Here are the most relevant search results for "Post-Authorization Safety Study of GSK Biologicals' Pandemic Influenza Vaccine (H1N1) in the United Kingdom" found in our extensive corporate database of over 50,000 company records.

Showing "Post Authorization Safety Study Biologicals Pandemic Influenza Vaccine" Companies 26–50 of 2,600+

Relevant

ImmunoBiology Limited (ImmBio)

Limited [ImmBio] is a biotechnology company specialising in the treatment of infectious diseases and cancer. ImmBio's approach is to apply advances in the emerging science of Immunobiology to the development of treatments for infections diseases and cancer. Immbio is developing a proprietary vaccine technology based on these advances. The platform technology is called HspC™ vaccination. HspC...


Variation Biotechnologies Inc

Variation Biotechnologies, Inc. (VBI) creates intelligent vaccines that learn from nature. Our management and scientific team consists of industry-leading experts that have increased our product pipeline and partnerships.After decades of vaccine research, Variosite™ technology evokes the full power of the immune system by mimicking the body's natural protection to infection. This novel vaccine s...

Shoo the Flu

The flu, also called influenza, is a contagious disease that spreads by coughing, sneezing and close contact. Flu symptoms include fever/chills, sore throat, muscle aches, fatigue, cough and headache. The flu is preventable. The flu vaccine is the most effective way to reduce the chances that people will get the flu and spread it to others. The Centers for...


Inovio Biomedical Corporation

Inovio Biomedical is focused on the design, development, and delivery of a new generation of vaccines, called DNA vaccines, to prevent and treat cancers and infectious diseases. The company’s SynCon™ technology enables the design of “universal” vaccines capable of protecting against multiple – including newly emergent, unknown – stra...

Mucosis

Mucosis B.V. is a clinical-stage biotechnology company developing novel vaccines on its proprietary Mimopath® platform technology. The Mimopath® platform is being studied for various routes of administration including those that provide additional protection in the mucosa, the site where over 90% of pathogens enter the human body. Mucosis’s lead...

British Biologicals

British Biologicals is an Indian Nutraceutical company, founded in 1988 by Mr. V S Reddy. British Biologicals is headquartered at Bangalore and is popularly known as 'The Protein People'. The company offers wide range of Nutraceutical science-based nutritional supplements that are distinctive, reliable and 100% safe for human consumption. British ...

FluGen Inc.

FluGen, Inc. is a clinical stage vaccine company focused on improving the breadth and effectiveness of influenza vaccines. The Company’s technology comes from the laboratory of Dr. Yoshihiro Kawaoka at the University of Wisconsin, Madison. It’s lead product candidate, RedeeFlu™ is a universal flu vaccine which is based on the knowledge that a ...

AdverseEvents Inc.

AdverseEvents, Inc. (AEI) is a California-based healthcare informatics company that improves patient safety and reduces systemic healthcare costs through the comprehensive analysis of post-marketing drug side effect data. Utilizing data-mining and analysis technology, through its proprietary RxSuite™ of analytics, AEI makes post-marketing drug safety ...

Sinovac Biotech

Sinovac Biotech Ltd. (also known in China as Beijing Kexing Bioproducts) specializes in the research, development, commercialization, and sales of human vaccines for infectious illnesses such as Hepatitis A and Hepatitis B, influenza and “SARS”. Sinovac is one of the leading emerging biotechnology companies in China. Working closely with Chinese public health officials, Sinovac focuses on man...

Geovax Labs

GeoVax is a Biotechnology company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus - AIDS) and other infectious agents. Our goals include: developing AIDS vaccines for global markets, manufacturing and testing these vaccines under GMP/GLP conditions (FDA guidelines), conducting phase I/II and III human trials for vaccine safety and effectiveness and obtaining r...

Novus Biologicals, Inc

The mission of Novus Biologicals, Inc. is to accelerate scientific discovery by marketing unique products in the forefront of science. Novus Biologicals was organized to provide the biological research community with a mechanism for commercializing unique biological materials and to monitor scientific trends and supply materials to serve these trends. We now offer over 10,000 antibodies to serve a...

Coalition for Vaccine Safety

Vaccine Safety Conference

PriorAuthNow

PriorAuthNow, Inc. is the leading electronic prior authorization (ePA) solution that enables healthcare providers and payers to leverage a single platform to submit, monitor and complete the prior authorization process. Based in Columbus, Ohio, PriorAuthNow’s powerful, secure software works with EMR systems and integrates directly with insurance carri...

Novus Biologicals Incorporated

Our mission at Novus Biologicals, Inc. is to supply monoclonal and polyclonal antibodies, recombinant protein and cDNAs for the scientific research community that are of high quality and applicability to current research trends and needs.supplier of prima

Drug Safety Alliance

Founded in 2000, Drug Safety Alliance (DSA) provides patient safety and pharmacovigilance expertise to large and small pharmaceutical and biotechnology companies to help them develop safe drugs and improve patient safety. Driven by the highest ethical standards, DSA is uniquely focused to provide high-quality pre- and post-market drug safety services inclu...

Crucell N.V

Crucell N.V. (NYSE Euronext, NASDAQ: CRXL; Swiss Exchange: CRX) is a global biopharmaceutical company focused on research development, production and marketing of vaccines, proteins and antibodies that prevent and/or treat infectious diseases. In 2009 alone, Crucell distributed more than 115 million vaccine doses in more than 100 countries around the world, with the fast majority of doses (97%...

Pharmexa

Pharmexa is a leading biotech company in the field of active immunotherapy and vaccines for the treatment of cancer, serious chronic and infectious diseases. The company has been listed on the Copenhagen Stock Exchange since 2000. The Pharmexa group consists of GemVax AS, a Norwegian subsidiary, developing peptide vaccines for cancer and Pharmexa-Epimmune, a US subsidiary, focusing on T cell epito...

GenVec

GenVec, Inc. (NASDAQ: GNVC) is a biopharmaceutical company developing novel gene-based therapeutic drugs and vaccines. Each of our gene-based therapeutic product candidates use a common patent-protected technology platform to deliver genes that produce medically beneficial proteins directly at the site of disease. TNFerade™ represents a novel approach to treating cancer in combination with rad...

Affinity Biologicals Inc

Affinity Biologicals Inc. (ABI) is now in it’s sixteenth year as a manufacturer of antibodies and antibody-related products for use in thrombosis and haemostasis research as well as medical diagnostics manufacturing. ABI has a quality system certified to ISO-13485 standards and is USFDA-QSR compliant. Our product line consists of more than 200 antibody products, matched-pair antibody sets for EL...

Selecta Biosciences, Inc.

Selecta Biosciences, Inc. is a biopharmaceutical company developing an entirely new class of targeted vaccines that induces an antigen-specific immune activation or antigen-specific immune tolerance for therapeutic and prophylactic applications. Selecta's proprietary Synthetic Vaccine Particle (SVP™) platform creates a new paradigm in vaccine developm...

The Washington Post

The Washington Post provides award-winning news and understanding about the politics, policies, personalities and institutions that make Washington, D.C. the world's seat of power, and is a critical tool and information source for those who call Washington, D.C. home. In digital form, The Washington Post combines its world-class journalism with the latest ...

Affinity Biologicals Incorporated

Affinity Biologicals Inc. is a manufacturer producing antibodies and antibody-related reagents and plasmas used in thrombosis and hemostasis research and in medical diagnostics manufacturing. A primary manufacturer of quality antibodies and plasmas.

TechnoVax

TechnoVax is a privately held biotechnology company based in Tarrytown (N.Y.) specializing in vaccine development using unique and innovative platform technologies. The company is committed to develop novel vaccines which are safer and more effective than those currently available. TechnoVax is presently evaluating in preclinical phase vaccines to protect ...

Lakewood-Amedex Inc.

Lakewood-Amedex is a privately held development-stage biopharmaceutical company with a broad patent portfolio of inventions, including, 24 granted and/or issued patents and 45 patent applications covering its proprietary NuBiotics family of anti-microbial products, proven to be effective against a wide range of bacteria, encompassing antibiotic resistant strains including methicillin-resistant Sta...


More From BioPortfolio on "Post-Authorization Safety Study of GSK Biologicals' Pandemic Influenza Vaccine (H1N1) in the United Kingdom"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks